Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows, ET HealthWorld
By Maggie FickLondon: Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking insulin ...
